Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Prostate Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    April 2025
  1. GUO X, Li S
    Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review).
    Oncol Rep. 2025;53:46.
    PubMed     Abstract available


    February 2025
  2. YANG C, Wang L, Gong C, Lv D, et al
    Antibody?drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review).
    Oncol Rep. 2025;53:21.
    PubMed     Abstract available


    November 2024
  3. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
    [Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
    Oncol Rep. 2024;52:152.
    PubMed     Abstract available


    October 2024
  4. NOURUZI S, Johnson F, Kumar S, Sivak O, et al
    Targeting adenocarcinoma and enzalutamide?resistant prostate cancer using the novel anti?androgen inhibitor ADA?308.
    Oncol Rep. 2024;52:132.
    PubMed     Abstract available


    June 2024
  5. LIU Y, Qin Z, Yang K, Liu R, et al
    [Corrigendum] Cripto?1 promotes epithelial?mesenchymal transition in prostate cancer via Wnt/beta?catenin signaling.
    Oncol Rep. 2024;51:75.
    PubMed     Abstract available


  6. PAN J, Tong F, Ren N, Ren L, et al
    Role of N(6)?methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review).
    Oncol Rep. 2024;51:88.
    PubMed     Abstract available


    May 2024
  7. HSIA YJ, Lin ZM, Zhang T, Chou TC, et al
    Butyrate increases methylglyoxal production through regulation of the JAK2/Stat3/Nrf2/Glo1 pathway in castration?resistant prostate cancer cells.
    Oncol Rep. 2024;51:71.
    PubMed     Abstract available


    March 2024
  8. PARAJULI KR, Jung Y, Taichman RS
    Abscisic acid signaling through LANCL2 and PPARgamma induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells.
    Oncol Rep. 2024;51:39.
    PubMed     Abstract available


    January 2024
  9. LEE DY, Chun JN, So I, Jeon JH, et al
    Oncogenic role of FOXM1 in human prostate cancer (Review).
    Oncol Rep. 2024;51:15.
    PubMed     Abstract available


    December 2023
  10. LEE DY, Lee S, Kim YS, Park S, et al
    Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK?dependent manner.
    Oncol Rep. 2023;50:218.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.